Related references
Note: Only part of the references are listed.Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
Mallik Greene et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N. Yatham et al.
BIPOLAR DISORDERS (2018)
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder
Joseph R. Calabrese et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
Markku Lahteenvuo et al.
JAMA PSYCHIATRY (2018)
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
Joseph R. Calabrese et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2018)
All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics
Tingjian Yan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database
Ming H. Hsieh et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study
Joseph R. Calabrese et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse
Jesus Salomon Martinez et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Effectiveness, Adverse Effects and Drug Compliance of Long-Acting Injectable Risperidone in Children and Adolescents
Mehmet Fatih Ceylan et al.
CLINICAL DRUG INVESTIGATION (2017)
Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: A 1-year retrospective cohort study
Hsue-Wei Chan et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder
Chi-Shin Wu et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Efficacy of Long-Acting Injectable Antipsychotics in Adolescents
Stephanie Pope et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2016)
Long-acting Injectable Risperidone Use in an 11-Years-Old Bipolar Child
Sevcan Karakoc Demirkaya et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2016)
Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics
Fuminari Misawa et al.
SCHIZOPHRENIA RESEARCH (2016)
Paliperidone Palmitate Depot in the Long-term Treatment of Psychotic Bipolar Disorder: A Case Series
Massimiliano Buoli et al.
CLINICAL NEUROPHARMACOLOGY (2015)
Olanzapine long-acting injection: When and for how long is oral supplementation required?
Majella Su-Xian Chew et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Long-acting injectable antipsychotics in early psychosis: a literature review
Robin Emsley et al.
EARLY INTERVENTION IN PSYCHIATRY (2013)
Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis of Mirror-Image Studies
Taishiro Kishimoto et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder
Alexandre Duarte Gigante et al.
CNS DRUGS (2012)
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
Eduard Vieta et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms
Wayne Macfadden et al.
BMC PSYCHIATRY (2011)
A Randomized Open Comparison of Long-Acting Injectable Risperidone and Treatment as Usual for Prevention of Relapse, Rehospitalization, and Urgent Care Referral in Community-Treated Patients With Rapid Cycling Bipolar Disorder
William V. Bobo et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features
Rao Narasimha Malempati et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Long-acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizers
Elisa Brietzke et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
A 34-Year-Old Mother with Religious Delusions, Filicidal Thoughts
Deborah Mendelson et al.
PSYCHIATRIC ANNALS (2011)
A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder
K. N. Roy Chengappa et al.
ACTA NEUROPSYCHIATRICA (2010)
Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
Jorge A. Quiroz et al.
BIOLOGICAL PSYCHIATRY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden et al.
BIPOLAR DISORDERS (2009)
Course and Outcome After the First Manic Episode in Patients With Bipolar Disorder: Prospective 12-Month Data From the Systematic Treatment Optimization Program for Early Mania Project
Lakshmi N. Yatham et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2009)
Use of Risperidone Long-Acting Injection to Support Treatment Adherence and Mood Stabilization in Pediatric Bipolar Patients: A Case Series
Lee Fu-I et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Maintenance Electroconvulsive Therapy Combined With Long-Acting Risperidone in the Treatment of Resistant Bipolar Affective Disorder
Cem Sengul et al.
JOURNAL OF ECT (2009)
Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients
Rao N. Malempati et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study
Peter Braeunig et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2008)
A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone
Eduard Vieta et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder
Changsu Han et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder
L. N. Yatham et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Use of long-acting risperidone in the treatment of bipolar patients
Haluk A. Savas et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Treatment adherence with antipsychotic medications in bipolar disorder
Martha Sajatovic et al.
BIPOLAR DISORDERS (2006)
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder
JR Calabrese et al.
BIOLOGICAL PSYCHIATRY (2004)
Long-term symptomatic status of bipolar I vs. bipolar II disorders
LL Judd et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
Treatment non-adherence in affective disorders
R Lingam et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
Share Paper
